SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-037833
Filing Date
2020-08-06
Accepted
2020-08-06 16:42:56
Documents
61
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q eigr-10q_20200630.htm   iXBRL 10-Q 2220357
2 EX-1.1 eigr-ex11_518.htm EX-1.1 288693
3 EX-5.1 eigr-ex51_457.htm EX-5.1 16515
4 EX-10.1 eigr-ex101_303.htm EX-10.1 15621
5 EX-31.1 eigr-ex311_9.htm EX-31.1 16842
6 EX-31.2 eigr-ex312_7.htm EX-31.2 16906
7 EX-32.1 eigr-ex321_10.htm EX-32.1 5743
8 GRAPHIC g5lssqbtxe4y000001.jpg GRAPHIC 26103
  Complete submission text file 0001564590-20-037833.txt   7557940

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA eigr-20200630.xsd EX-101.SCH 44059
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eigr-20200630_cal.xml EX-101.CAL 42899
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eigr-20200630_def.xml EX-101.DEF 147047
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE eigr-20200630_lab.xml EX-101.LAB 345137
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eigr-20200630_pre.xml EX-101.PRE 257437
14 EXTRACTED XBRL INSTANCE DOCUMENT eigr-10q_20200630_htm.xml XML 1299419
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36183 | Film No.: 201082356
SIC: 2836 Biological Products, (No Diagnostic Substances)